The rocket launcher spinout of TUM has received $90.8m in a UVC Partners-backed round as it prepares for a first commercial launch in 2022.

University of Oxford joined Oxford Sciences Innovation to back neuromuscular disease therapy spinout PepGen, which will move its base to the US.

Max Planck Society's TTO is celebrating its 50th anniversary having formed 160 spinouts since the early 1990s.

Heidelberg and Inserm have scored exits after an acquisition that followed MYR's chronic hepatitis delta virus treatment receiving European regulatory approval.

The rocket launcher developer has received $90.8m in an Airbus Ventures-backed round as it prepares for a first commercial launch in 2022.

Amazon Web Services, GV, Orange Ventures, Telekom Investment Pool, Sonae IM and Ericsson all took part in a $36.7m round for the cloud software technology provider.

Venture firm Target Global has hired Christian Noske, previously head of corporate venturing partnership Alliance Ventures, as its latest partner.

European Circular Bioeconomy Fund, which has hired Solvay Ventures alumnus Stéphane Roussel as a venture partner made a first close in October.

Swiss Re subsidiary IptiQ led the digital insurance app developer’s series B round, which increased its overall funding to $53m.

Science Creates will combine a $20m fund with wet-lab incubation to foster the west of England deep tech ecosystem in partnership with University of Bristol.